Important Treatment Considerations for Patients with Relapsed or Refractory Multiple Myeloma

GlaxoSmithKline
September 17, 2020


Join a clinical educator as she provides an in-depth review of a treatment for patients with relapsed or refractory multiple myeloma. This presentation will discuss important prescribing information, clinical data, and address other commonly asked questions.

Session: Important Treatment Considerations for Patients with Relapsed or Refractory Multiple Myeloma
Speaker: Lisa Briggs, OCE